nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2025, 04, v.5 5-8
循环氧代谢指标监测与超声指标监测在脓毒性休克患者容量管理中的对比研究
基金项目(Foundation): 益阳市中心医院院级科研计划项目(2022QN02)
邮箱(Email):
DOI:
摘要:

目的:探讨循环氧代谢指标[中心静脉血氧饱和度(ScvO2)、静脉-动脉二氧化碳分压差(P(v-a)CO2)]与超声指标(下腔静脉宽度及变异度、心脏功能参数、肺部B线)在脓毒性休克患者容量管理中的应用价值及相关性,以优化液体复苏策略。方法:选取益阳市中心医院2023-01至2025-03收治的180例脓毒性休克患者(血乳酸> 4 mmol/L),按氧代谢指标(ScvO2、P(v-a)CO2)分为4组(A-D组),按超声指标(下腔静脉宽度及变异度)分为6组(E-J组)。所有患者均接受液体复苏治疗,以氧代谢达标(ScvO2 > 70%、P(v-a)CO2<6 mmHg)和超声达标(下腔静脉宽度> 20 mm、变异度<50%)为终点,记录(复苏前及复苏后24 h)的指标变化,比较输液总量、肺水肿发生率及指标相关性。结果:A组(ScvO2<70%、P(v-a)CO2 > 6 mmHg)复苏后下腔静脉变异度显著降低(P<0.05),心脏指数(CI)、心输出量(CO)显著升高(P<0.05);D组(ScvO2 > 70%、P(v-a)CO2<6mmHg)肺水肿发生率最低(8.33%)。E组(下腔静脉宽度<10 mm、变异度> 50%)复苏后ScvO2显著升高(P<0.05),P(v-a)CO2显著降低(P<0.05);J组(下腔静脉宽度> 20 mm、变异度<50%)氧代谢达标率最高(91.67%)。同时参考氧代谢与超声指标的患者输液总量更少(P<0.05),肺水肿发生率显著低于单一指标组(P<0.05)。复苏后6~12 h,氧代谢与超声指标的一致性达78.33%,且与器官功能恢复评分(SOFA)呈负相关(r=-0.421,P<0.01)。结论:循环氧代谢指标与超声指标在脓毒性休克容量管理中具有互补性,联合监测可优化液体复苏策略,减少过量补液风险,改善患者预后。

Abstract:

Objective: To explore the application value and correlation of circulating oxygen metabolism indicators [(central venous oxygen saturation(ScvO2), venous-to-arterial carbon dioxide partial pressure difference(P(v-a)CO2)] and ultrasound indicators(inferior vena cava width and variability, cardiac function parameters, and lung B-line) in volume management of patients with septic shock, so as to optimize fluid resuscitation strategies. Methods: A total of 180 patients with septic shock(blood lactate>4 mmol/L) admitted to Yiyang Central Hospital from January 2023 to March 2025 were selected and divided into 4 groups(A-D groups) based on oxygen metabolism indicators(Scv O2, P(v-a) CO2) and 6 groups(E-J groups) based on ultrasound indicators(inferior vena cava width and variability). All patients received fluid resuscitation treatment, with oxygen metabolism reaching the standard(ScvO2>70%, P(v-a) CO2<6 mmHg) and ultrasound reaching the standard(inferior vena cava width>20 mm, variability<50%) as endpoints. Changes in indicators(before and 24 h after resuscitation) were recorded, and the total amount of infusion, incidence of pulmonary edema, and correlation between indicators were compared. Results: After resuscitation, inferior vena cava variability in Group A(ScvO2<70%, P(v-a)CO2>6 mmHg) significantly decreased(P<0.05), while the cardiac index(CI) and cardiac output(CO) significantly increased(P<0.05). Group D(ScvO2>70%, P(v-a)CO2<6 mmHg) had the lowest incidence of pulmonary edema(8.33%). After resuscitation, ScvO2 significantly increased(P<0.05) and P(v-a)CO2 significantly decreased(P<0.05) in group E(inferior vena cava width<10 mm, variability>50%). Group J(inferior vena cava width>20 mm, variability<50%) had the highest oxygen metabolism compliance rate(91.67%). Patients who referred to both oxygen metabolism and ultrasound indicators had a lower total volume of infusion(P<0.05) and a significantly lower incidence of pulmonary edema compared to the single indicator group(P<0.05). After 6-12 h of resuscitation, the consistency between oxygen metabolism and ultrasound indicators reached 78.33%, and was negatively correlated with Sequential Organ Failure Assessment(SOFA)(r=-0.421, P<0.01). Conclusion: Circulating oxygen metabolism indicators and ultrasound indicators complement each other in volume management of septic shock. Combined monitoring can optimize fluid resuscitation strategies, reduce the risk of excessive fluid replacement, and improve patient prognosis.

参考文献

[1]师华华,刘天瑜,张彦峰,等.CCUS监测下容量性指标在脓毒症休克液体容量管理中的应用[J].现代科学仪器,2023,40(2):49-53.

[2]严颜,魏捷,吴淼,等.脓毒症的微循环监测与管理:从临床实践出发[J].临床急诊杂志,2024,25(2):99-104.

[3]周亚敏,郭加伟,王金苹.无创超声心排血量监测仪在指导脓毒性休克患儿容量管理中的应用[J].实用医技杂志,2022, 29(1):4.

[4]王逸君,许可,乐冬友,等.TTE和PiCCO对脓毒性休克患者行血流动力学监测及指导容量管理的价值分析[J].中国现代药物应用,2022,16(23):69-72.

[5]刘帅,王泽熙,史海燕,等.床旁超声联合肺泡动脉氧分压差在儿童脓毒性休克液体复苏中的临床应用[J].河北医科大学学报,2024,45(5):508-512.

[6]王逸君,莫晓君,许可,等.TTE与PICCO联合监测指导脓毒性休克患者救治的临床应用研究[J].实用休克杂志(中英文),2022,6(5):274-280.

[7]马俊,谢沥影,周雨希,等.NT-proBNP联合ScvO_(2)在脓毒性休克患者容量管理指导中的意义[J].中国医学创新,2022,19(9):148-152.

[8]廖磊,周贺民,杨迪.无创血流动力学监测指导下液体复苏对脓毒性休克患者氧代谢及TNF-α,IL-1β,IL-6的影响[J].实验与检验医学,2024,42(1):63-66.

[9]徐欣欣,白静,冯凯,等.脉搏灌注指数监测评估脓毒症及脓毒性休克患者血流动力学的研究进展[J].中华急诊医学杂志,2022,31(11):4.

[10]吴苏明,李智,许晓函.监测舌下微循环,经皮氧代谢对脓毒症患者疾病严重程度及近期预后判断的价值分析[J].临床和实验医学杂志,2023,22(16):1721-1724.

[11]王丽晖,姬骁亮,刘文悦.代谢复苏疗法在脓毒性休克患者中的临床意义[J].临床急诊杂志,2022,23(8):5.

[12]彭鑫,郑峰,朱滨,等.二氧化碳衍生指标在脓毒症患者中诊疗价值的研究进展[J].中华危重病急救医学,2024,36(4):435-440.

基本信息:

中图分类号:R459.7

引用信息:

[1]黎有富,庄水龙.循环氧代谢指标监测与超声指标监测在脓毒性休克患者容量管理中的对比研究[J].医用气体工程,2025,5(04):5-8.

基金信息:

益阳市中心医院院级科研计划项目(2022QN02)

发布时间:

2025-08-28

出版时间:

2025-08-28

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文